Export

Sodium stibogluconate
Essential medicine status
Section:
6. Anti-infective medicines 6.5. Antiprotozoal medicines 6.5.2. Antileishmaniasis medicines
ATC codes: P01CB02
EMLc
Indication
Cutaneous leishmaniasis ICD11 code: 1F54.1
INN
Sodium stibogluconate
Medicine type
Chemical agent
List type
Core
Formulations
Parenteral > General injections > unspecified: 100 mg per mL in 30 mL vial
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1984 (TRS 722)
Removed in 1989 (TRS 796)
Added in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Sodium stibogluconate
DrugBank
Sodium stibogluconate
Summary of evidence and Expert Committee recommendations
The 2007 recommendations of the EMLc Subcommittee for the listings of sodium stibogluconate and meglumine antimoniate were applied to the EML.